{"id":"NCT02180672","sponsor":"Children's Hospital of Philadelphia","briefTitle":"Steroids for Pediatric Apnea Research in Kids","officialTitle":"Utility of Nasal Steroids for Treatment of Childhood Obstructive Sleep Apnea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09","primaryCompletion":"2019-12-30","completion":"2021-10-30","firstPosted":"2014-07-03","resultsPosted":"2021-03-10","lastUpdate":"2021-11-10"},"enrollment":211,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Obstructive Sleep Apnea Syndrome"],"interventions":[{"type":"DRUG","name":"Nasal Fluticasone","otherNames":["NCS","Nasal steroids","Nasal corticosteroids"]},{"type":"DRUG","name":"Placebo","otherNames":["Saline"]}],"arms":[{"label":"Nasal steroids","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This double-blind, randomized controlled trial will evaluate the use of nasal corticosteroids for the treatment of the childhood obstructive sleep apnea syndrome (OSAS). Efficacy, duration of action and side-effects will be determined.","primaryOutcome":{"measure":"Obstructive Apnea Hypopnea Index","timeFrame":"3 months","effectByArm":[{"arm":"Nasal Steroids","deltaMin":7.69,"sd":null},{"arm":"Placebo","deltaMin":6.33,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["40051199","35779610"],"seeAlso":["http://www.research.chop.edu/research/clinical-research"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":86},"commonTop":["Upper Respiratory Tract (including cough)","Other Illness","Lower Respiratory Tract (Including Asthma)","Gastrointestinal Tract","Other Infections"]}}